Compound library / Longevity / Metabolic
Fibric acid derivative (fibrate) that activates PPARα to lower triglycerides and raise HDL; FDA-approved for dyslipidemia. Also being explored in longevity contexts as a potential complement to rapamycin-adjacent mTOR/AMPK-pathway protocols.
| Category | Longevity / Metabolic |
|---|---|
| Typical route | Oral |
| Half-life | ~20 hours |
| Common dose range | 48-145 mg/day (Tricor-equivalent; doses vary by formulation) |
| Typical cycle length | Ongoing under medical supervision |
BioHack Track models Fenofibrate at a half-life of 20 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Oral tablet/capsule; no reconstitution needed.
Store at room temperature.
Prescription medication. Can cause muscle pain (myopathy) especially with statins; monitor liver enzymes and kidney function. Bile duct stone risk with prolonged use.
Track Fenofibrate in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Fenofibrate — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.